Business · 03/10/2018Updated: 10/17/2026 · 1 min read
FDA Releases Draft Guidance on Citizen Petitions and Stay of Action for 505(q) Petitions
Summary
The FDA is releasing a revised draft guidance on citizen petitions and stay of action for 505(q) petitions, which updates the 2014 guidance to reflect recent regulatory changes and FDA's new thinking on what constitutes a 505(q) petition.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →